Lantern Pharma Reports Third Quarter 2021 Financial Results

/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...

Related Keywords

Boston , Massachusetts , United States , Dallas , Texas , David Waldman , Igor Astsaturov , Nicholas Koulermos , Kishorg Bhatia , Johns Hopkins University , Exchange Commission On , Crescendo Communications , Twitter , Drug Administration , Exchange Commission , Lantern Pharma Inc , Securities Exchange , Society Of Neuro Oncology , Panna Sharma , Lantern Pharma , Subsequent Highlights , Orphan Drug Designation , Special Conference , Pancreatic Cancer , Atypical Teratoid Rhabdoid Tumor , Deep Lens , Code Ocean , Drug Designations , Upcoming Milestones , Key Opinion Leader , Conchetta Greenberg Pancreatic Cancer Institute , Fox Chase Cancer Center , Chief Scientific Officer , World Pancreatic Cancer Day , Neuro Oncology , Securities Act , Securities Exchange Act , Risk Factors , Annual Report , Vice President ,